Breakthrough in cancer treatment
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.An important hurdle has been crossed by scientists attempting to develop the world's first cancer vaccine, it was announced yesterday. Researchers in the US reported the first hard evidence that a vaccine works in patients and has practical potential.
In one of the first trials of a genetically engineered vaccine, a team at the Johns Hopkins Oncology Centre in Baltimore, Maryland, succeeded in activating patients' immune systems.
The vaccine was given to 18 patients with advanced kidney cancer to test its safety and effectiveness over an eight-year period. One patient, whose tumour continued to grow and spread to his lungs after surgery, showed a substantial improvement for several months after receiving the vaccine.
Although the rest showed no signs of remission, all had measurable immune responses. Many patients died within the first year of the trial.
The findings are reported in the journal Cancer Research.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments